UK10K

UK10K
Name	UK10K
Start	2010
End	2013
Location	United Kingdom
Funder	Wellcome Trust
Lead	Sanger Institute
Participants	8,000
Focus	Whole-genome and exome sequencing

UK10K

The UK10K project was a large-scale population sequencing initiative that used whole-genome and exome sequencing to investigate human genetic variation, rare variants and their links to disease. It brought together researchers from institutions such as the Wellcome Trust Sanger Institute, the University of Cambridge, the University of Oxford, the European Bioinformatics Institute, and clinical cohorts including the TwinsUK, ALSPAC, and UK Biobank-related groups. The project generated resources used by consortia, funders and initiatives like the 1000 Genomes Project, the Exome Aggregation Consortium, and the International HapMap Project.

Background and objectives

The initiative was conceived amid growing interest from organizations such as the Wellcome Trust, the Medical Research Council (United Kingdom), and the National Institute for Health Research in leveraging next-generation sequencing technologies pioneered by companies like Illumina and centers including the Sanger Institute and Broad Institute. Objectives targeted discovery of rare variants influencing phenotypes studied in cohorts such as ALSPAC (Avon Longitudinal Study of Parents and Children), TwinsUK, EPIC-Norfolk, and disease-specific cohorts linked to Type 2 diabetes, Schizophrenia, Asthma, and cardiovascular traits investigated by groups from the University College London and Imperial College London. Outputs aimed to inform projects with translational goals championed by institutions like Genomics England and international efforts including the Human Genome Project.

Study design and methods

The study sequenced roughly 4,000 whole genomes and 6,000 exomes drawn from population cohorts and disease collections, combining high-throughput platforms from Illumina and analysis pipelines influenced by methods developed at the Broad Institute and European Bioinformatics Institute. Sample ascertainment incorporated cohorts such as Generation Scotland, ALSPAC, TwinsUK, and disease-focused collections assembled at King's College London and University of Oxford. Bioinformatics workflows used tools and resources associated with Ensembl, the UCSC Genome Browser, and variant databases like dbSNP and the 1000 Genomes Project reference panels. Quality control and variant calling adopted algorithms and standards propagated by groups at the Sanger Institute, Broad Institute, and the European Molecular Biology Laboratory, integrating annotations from resources maintained by the National Center for Biotechnology Information.

Findings and data release

Analyses reported thousands of low-frequency and rare variants across coding and non-coding regions, implicating loci relevant to traits studied in cohorts such as lipid measures linked to research at University of Oxford and metabolic phenotypes studied by teams at University of Cambridge and Imperial College London. Aggregate variant catalogs complemented public datasets like the 1000 Genomes Project and later informed the Exome Aggregation Consortium and databases used by the ClinGen and ClinVar initiatives. The consortium released summary statistics, variant calls and sequence read data to controlled-access archives managed by infrastructure partners including the European Genome-phenome Archive and repositories used by the Wellcome Trust Sanger Institute, enabling downstream analyses by researchers at institutions such as Harvard University, Stanford University, Massachusetts Institute of Technology, University of California, San Francisco, and international collaborators from the Max Planck Society and Karolinska Institutet.

Impact on genomics and medicine

Outputs influenced methods and projects across translational initiatives including Genomics England's 100,000 Genomes Project and aided interpretation frameworks used by clinical laboratories interacting with NHS England services. UK10K-derived data supported studies by consortia like the International Common Disease Alliance and informed pharmacogenomics and rare-disease gene discovery efforts at centers such as Great Ormond Street Hospital and the MRC Centre for Genomics and Global Health. The project helped shape variant interpretation standards developed by groups including the American College of Medical Genetics and Genomics and resources produced by the Human Variome Project and contributed to follow-up work published by teams at University College London and Wellcome Trust Sanger Institute.

Collaborations and funding

Major funders and partners included the Wellcome Trust, the Medical Research Council (United Kingdom), academic partners such as the Sanger Institute, University of Cambridge, University of Oxford, University College London, and clinical cohorts like TwinsUK and ALSPAC. International collaborations connected investigators from the Broad Institute, Harvard Medical School, Stanford University School of Medicine, and European centres including the European Bioinformatics Institute, Karolinska Institutet, and the Max Planck Society. Technology and analysis partners included Illumina, infrastructure providers such as the European Genome-phenome Archive, and computational groups influenced by methods from the Broad Institute and European Molecular Biology Laboratory.

Ethical, legal and social issues

The project navigated data access and participant consent frameworks interacting with policy bodies such as NHS England, the Health Research Authority, and funders like the Wellcome Trust. Data governance aligned with controlled-access models used by archives such as the European Genome-phenome Archive and informed debates in fora including the Genomics England ethics advisory structures and international discussions involving the Council of Europe and the Organisation for Economic Co-operation and Development. Concerns addressed included re-identification risks raised in meetings at institutions like University College London and legal-ethical discourse contributed by scholars from King's College London and University of Oxford.

Category:Genomics projects